Japan, Nov. 17 -- MIRADX has got intellectual property rights for 'BIOMARKERS FOR PREDICTING TUMOR RESPONSE TO AND TOXICITY OF IMMUNOTHERAPY.' Other related details are as follows:
Application Number: JP,2023-149977
Category (FI): C12Q1/6883@Z,A61K39/395@T,A61K39/395@U,A61K45/00,A61K51/00,A61P35/00,A61P35/02,C12Q1/6888@Z
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Sept. 15, 2023
Publication Date: Nov. 2, 2023
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
